Clearline Capital »

Vor Biopharma shares owned by Clearline Capital

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Clearline Capital from 13F filings

Historical chart of Clearline Capital investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Clearline Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Clearline Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.8M 326k 17.84

More positions owned by Clearline Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Core Scientific (CORZ)
NVIDIA Corporation (NVDA)
Rogers Corporation (ROG)
Vistra Energy (VST)
Primo Brands Corporation Class A Com Shs (PRMB)
Echostar Corp Cl A (SATS)
Micron Technology (MU)
Talen Energy Corp (TLN)
Novanta (NOVT)
Advanced Micro Devices (AMD)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Parsons Corporation (PSN)
Semtech Corporation (SMTC)

View all positions for Clearline Capital

Top funds holding Vor Biopharma

TCG Crossover Management
RA Capital Management
Fcpm Iii Services B.v.
VR Adviser
Frazier Life Sciences Management
FMR
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Vanguard Capital Management
Susquehanna International
Caligan Partners
BlackRock
Vanguard Group
Logos Global Management
Boothbay Fund Management

View all funds holding Vor Biopharma